22q11.2 Deletion Syndrome (DiGeorge): Two cases, two outcomes. The importance of prenatal identification

22q11.2 deletion syndrome, also known as DiGeorge, is caused by a missing section of chromosome 22. It is more common than other conditions routinely screened for prenatally such as cystic fibrosis, s

Fetal RhD NIPT: Transforming care for Rh negative pregnant patients

Until recently, there has not been a reason to diverge from the standard approach of giving Rh immune globulin to all Rh negative patients. That has changed with the introduction of fetal RhD NIPT, no

22q11.2 Deletion Syndrome (DiGeorge): Its impact on families and why early detection matters

The evolution of NIPT: what comes next

In this talk, we will highlight how early, highly accurate prenatal screening optimizes outcomes for patients with 22q11.2 deletion syndrome, and review recently-published data from a large clinical v

Fetal RhD NIPT: A new testing option to inform care for RhD alloimmunized patients and those at risk

Natera™'s Fetal RhD NIPT (noninvasive prenatal testing) is now available. The test is backed by the largest clinical validation study for fetal RhD in the US to date, and demonstrated 100 percent sens

It's time to screen routinely for 22q11.2 deletion syndrome: new evidence of improved outcomes with prenatal diagnosis

To manage pregnancies at high risk for 22q11.2 deletion syndrome (DS), prenatal and neonatal evaluation after high risk cfDNA screening is needed. Supplemental assessments and early intervention can i

Carrier Manifestations in Pregnancy

Utility of carrier screening to inform management

Natera Webinar Series Part III: What’s SMART about screening for sex chromosome trisomies : early intervention matters

Natera Webinar Series Part II: NIPT for 22q11.2 DS: Does evidence support routine screening?

During this webinar series, Natera’s medical leadership team will review publications with significant findings from SNP-based NIPT results.

Natera Webinar Series Part I: Suspected maternal malignancies detected by NIPT: what you need to know - Direct

Review what is known about noninvasive prenatal screening and incidental findings associated with maternal malignancy.

Webinar: Clinical experience with SNP-based NIPT for aneuploidy detection in twins

This webinar will focus on our recent publication in Prenatal Diagnosis — Positive predictive value of a single nucleotide polymorphism (SNP)‐based NIPT for aneuploidy in twins.